» Articles » PMID: 30008712

Strain-Specific Contribution of Eukaryotic Elongation Factor 1 Gamma to the Translation of Influenza A Virus Proteins

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2018 Jul 17
PMID 30008712
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Influenza A virus exploits multiple host proteins during infection. To define the virus-host interactome, our group conducted a proteomics-based screen and identified 299 genes that contributed to virus replication and 24 genes that were antiviral. Of these genes, we focused on the role during virus replication of eukaryotic elongation factor 1 gamma (eEF1G), which is a subunit of the eukaryotic elongation factor-1 complex and known to be a pro-viral host protein. Using the CRISPR/Cas9 system, we obtained two clones that were defective in eEF1G expression. In both of these clones, A/WSN/33 (H1N1) virus growth and protein expression were significantly suppressed, but viral mRNA, vRNA, and cRNA expression were not reduced. However, the replication and protein expression of A/California/04/2009 (H1N1pdm) virus in both clones were similar to those in parental cells. We found that the PB2 and PA proteins of WSN virus were responsible for the eEF1G-dependent replication. Our data show that eEF1G plays a role in the translation of virus proteins in a strain-specific manner. Additional analyses may be needed to further understand the role of strain-specific host proteins during virus replication.

Citing Articles

Reovirus infection induces transcriptome-wide unique A-to-I editing changes in the murine fibroblasts.

Tariq A, Piontkivska H Virus Res. 2024; 346:199413.

PMID: 38848818 PMC: 11225029. DOI: 10.1016/j.virusres.2024.199413.


infection upregulates and engages host macrophage Argonaute 1, and system-wide proteomics reveals Argonaute 1-dependent host response.

Moradimotlagh A, Chen S, Koohbor S, Moon K, Foster L, Reiner N Front Immunol. 2023; 14:1287539.

PMID: 38098491 PMC: 10720368. DOI: 10.3389/fimmu.2023.1287539.


Intrinsic targeting of host RNA by Cas13 constrains its utility.

Li Z, Li Z, Cheng X, Wang S, Wang X, Ma S Nat Biomed Eng. 2023; 8(2):177-192.

PMID: 37872368 DOI: 10.1038/s41551-023-01109-y.


Clinically Evaluated COVID-19 Drugs with Therapeutic Potential for Biological Warfare Agents.

Dechtman I, Ankory R, Sokolinsky K, Krasner E, Weiss L, Gal Y Microorganisms. 2023; 11(6).

PMID: 37375079 PMC: 10304720. DOI: 10.3390/microorganisms11061577.


Plitidepsin: Mechanisms and Clinical Profile of a Promising Antiviral Agent against COVID-19.

Papapanou M, Papoutsi E, Giannakas T, Katsaounou P J Pers Med. 2021; 11(7).

PMID: 34357135 PMC: 8306251. DOI: 10.3390/jpm11070668.


References
1.
Karlas A, Machuy N, Shin Y, Pleissner K, Artarini A, Heuer D . Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature. 2010; 463(7282):818-22. DOI: 10.1038/nature08760. View

2.
Watanabe T, Kawakami E, Shoemaker J, Lopes T, Matsuoka Y, Tomita Y . Influenza virus-host interactome screen as a platform for antiviral drug development. Cell Host Microbe. 2014; 16(6):795-805. PMC: 4451456. DOI: 10.1016/j.chom.2014.11.002. View

3.
Riis B, Rattan S, Clark B, Merrick W . Eukaryotic protein elongation factors. Trends Biochem Sci. 1990; 15(11):420-4. DOI: 10.1016/0968-0004(90)90279-k. View

4.
Yamayoshi S, Noda T, Ebihara H, Goto H, Morikawa Y, Lukashevich I . Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transport. Cell Host Microbe. 2008; 3(3):168-77. PMC: 2330329. DOI: 10.1016/j.chom.2008.02.001. View

5.
Palese P, SCHULMAN J . Mapping of the influenza virus genome: identification of the hemagglutinin and the neuraminidase genes. Proc Natl Acad Sci U S A. 1976; 73(6):2142-6. PMC: 430466. DOI: 10.1073/pnas.73.6.2142. View